Zobrazeno 1 - 10
of 63
pro vyhledávání: '"N. L. Kozlovskaya"'
Autor:
S. K. Solovyev, N. L. Kozlovskaya, E. A. Aseeva, A. A. Baranov, N. Yu. Nikishina, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 1, Pp 55-64 (2024)
Lupus nephritis (LN) is considered to be one of the most frequent severe manifestations of systemic lupus erythematosus (SLE), its various colonic manifestations occur in at least 50% of SLE patients, both at the onset and at various stages of the di
Externí odkaz:
https://doaj.org/article/5b556084d5904e0991461f15a29a84bd
Autor:
V. M. Sheludchenko, N. L. Kozlovskaya, D. V. Andzhelova, E. I. Krasnolutskaya, T. V. Smirnova
Publikováno v:
Oftalʹmologiâ, Vol 20, Iss 2, Pp 319-325 (2023)
Color Doppler imaging allows a detailed non-invasive assessment of the state of blood flow in the retrobulbar vessels in patients with various vascular pathologies. Malignant hypertension (MH) is a clinical syndrome characterized by severe diastolic
Externí odkaz:
https://doaj.org/article/ce8c71671f0f40a38f3dfe4185cfcefd
Publikováno v:
Современная ревматология, Vol 15, Iss 4, Pp 94-100 (2021)
Over the past 50 years the survival rate of patients with systemic lupus erythematosus (SLE) significantly improved, however, it is necessary to develop a new generation of drugs for the treatment of lupus nephritis (LN), the development of which is
Externí odkaz:
https://doaj.org/article/89a57bb52238467aa7734468e3227dbb
Autor:
R. A. Osipyants, M. Z. Kanevskaya, N. L. Kozlovskaya, K. A. Demyanova, M. M. Saidova, A. V. Bespalova, T. Sh. Mirilashvili
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 2, Pp 225-228 (2021)
A clinical case of a patient with active rheumatoid arthritis (RA) resistant to standard basic therapy is presented, which served as the reason for the appointment of the target drug – Janus kinase, tofacitinib (Jaquinus) and then biological therap
Externí odkaz:
https://doaj.org/article/6f6e01f41a32417893cf4298caca2064
Autor:
N. L. Kozlovskaya, S. K. Solovyev, E. A. Aseeva, T. V. Popkova, T. A. Panafidina, E. L. Nasonov, A. M. Lila, A. A. Mesnyankina, N. Yu. Nikishina
Publikováno v:
Современная ревматология, Vol 15, Iss 1, Pp 9-14 (2021)
The paper presents the main provisions of the updated 2019 EULAR/ERA-EDTA guidelines for the lupus nephritis (LN) therapy, which have been prepared by an international group of rheumatologists, nephrologists, morphologists, and pediatricians. Part 2
Externí odkaz:
https://doaj.org/article/ad037bdef3f84450bdb0d2dfadb97703
Autor:
N. L. Kozlovskaya, S. K. Solovyev, E. A. Aseeva, T. V. Popkova, T. A. Panafidina, E. L. Nasonov, A. M. Lila, A. A. Mesnyankina, N. Yu. Nikishina
Publikováno v:
Современная ревматология, Vol 14, Iss 4, Pp 7-15 (2020)
The paper presents the main provisions of the 2019 updated European League Against Rheumatism (EULAR)/European Renal Association (ERA) – European Dialysis and Transplant Association (EDTA) guidelines for the management of lupus nephritis. It discus
Externí odkaz:
https://doaj.org/article/282aaa188cb3413cbbfe9a1da968d5ed
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 10, Iss 6, Pp 640-645 (2015)
Aim. To compare prognostic impact of community-acquired and hospital-acquired hyponatremia in hospitalized patients with decompensated heart failure Material and methods. Data of 120 patients with decompensated heart failure were analyzed. Hyponatrem
Externí odkaz:
https://doaj.org/article/d3875389529243cd919fce32b701b65b
Autor:
Tatiana Bondarenko, N L Kozlovskaya, Olga A. Volkova, Kseniia A. Demyanova, Artem O. Lugovoj, Anna V. Bespalova, Galina V. Usatenko, Sergei V. Apresyan, Mariia A. Vorobyeva, Yuliia V. Korotchaeva, Lidiia P. Rylceva
Publikováno v:
Терапевтический архив, Vol 93, Iss 6, Pp 685-692 (2021)
Pregnancy in patients with advanced chronic kidney disease (CKD) is associated with a high risk of adverse outcomes for the mother and the fetus, but data on the characteristics of the course of pregnancy in these women is limited.To analyse of the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::827555f2ba6362c20ae893e7ee3ca8dd
https://ter-arkhiv.ru/0040-3660/article/viewFile/75950/56515
https://ter-arkhiv.ru/0040-3660/article/viewFile/75950/56515
Autor:
A. M. Lila, S. K. Solovyev, N. L. Kozlovskaya, E. A. Aseeva, A. A. Mesnyankina, N. Yu. Nikishina, Nasonov El, Tatiana Popkova, T.A. Panafidina
Publikováno v:
Современная ревматология, Vol 15, Iss 1, Pp 9-14 (2021)
The paper presents the main provisions of the updated 2019 EULAR/ERA-EDTA guidelines for the lupus nephritis (LN) therapy, which have been prepared by an international group of rheumatologists, nephrologists, morphologists, and pediatricians. Part 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8445d40321de6063e766bc3e17a1bc6
https://mrj.ima-press.net/mrj/article/view/1093
https://mrj.ima-press.net/mrj/article/view/1093
Autor:
Abram Syrkin, A A Bykova, S A Suchkova, M I Chashkina, A Yu Suvorov, Z K Salpagarova, Denis Andreev, N L Kozlovskaya
Publikováno v:
Kardiologiia. 60:94-100
Aim To evaluate safety of using rivaroxaban in patients with stage 4 chronic kidney disease (CKD) or transient, stable decline of glomerular filtration rate (GFR) to 15–29 ml /min / 1.73 m2 in the presence of atrial fibrillation (AF).Material and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2db4b0daa81979c84d1f081397e3723d
https://doi.org/10.18087/cardio.2020.11.n1322
https://doi.org/10.18087/cardio.2020.11.n1322